Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore, firm declares Rs 5.50 dividend

Sun Pharma Q4 net profit declines 19% to Rs 2,154 crore.

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Sun Pharmaceutical Industries Ltd on Thursday reported a 19 percent decline in its consolidated net profit to Rs 2,153.9 crore in the fourth quarter ended March 31, 2025. The company had posted a consolidated net profit of Rs 2,658.7 crore in the year-ago period, Sun Pharmaceutical Industries said in a statement.

Consolidated total revenue from operations grew 8.1 percent during the quarter under review stood at Rs 12,958.8 crore as compared to Rs 11,983 crore in the corresponding period a year ago, it added.

The company's board has declared a final dividend of Rs 5.50 per share for the FY25. The company in a statement said, "the Meeting of the Board of Directors of the Company was held today, i.e. 22 May 2025. The Board has recommended final dividend of Rs. 5.50/- (Rupees Five and Paise Fifty only) per equity share of Re. l/- (Rupee One only) each is recommended to the shareholders for their approval at the ensuing Annual General Meeting of the Company."

"Monday, 07 July 2025 is fixed as the Record Date for the purpose of determining the Members eligible to receive the final dividend, which, if approved at the Annual General Meeting, shall be paid on or before Friday, 08 August 2025," it added.

The earnings before interest, taxes, depreciation and amortization (EBITDA) grew 22.4 percent to Rs 3,715.9 crore in Q4FY25, compared to Rs 3,035.15 crore in the same period, a year ago, while the margin stood at 28.7 percent against 25.3 percent YoY.

Shares of Sun Pharmaceutical Industries Ltd settled flat in Thursday's trade at Rs 1,724.7 per share on the NSE, down 0.41 percent.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.